Sucralfate
Brand names: Sucralfate, Carafate
At a glance
- Medicare prescriptions, 2024
- 1,620,706
- Medicare drug cost
- $86.4M
- Average cost per prescription
- $53.29
- Clinicians who prescribed it
- 53,360
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
INDI C A T I O N S A ND U S A G E CARAFATE ® (sucralfate) is indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
From the FDA-approved prescribing information (label dated May 2024). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 25.9%
- Internal Medicine 20.9%
- Nurse Practitioners 18.5%
- Gastroenterology 16.4%
- Physician Assistants 6.0%
- General Practice 3.0%
- General Surgery 2.1%
- Geriatric Medicine 1.7%
- Emergency Medicine 1.1%
- Hospitalist 0.8%
- Cardiology 0.4%
- Pulmonology 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 14% from 2019 to 2024.
Biggest change by state since 2019
- Puerto Rico +39%
- Utah +37%
- Florida +26%
- Washington +25%
- New Mexico +24%
- Maine (smallest change) +0%
- New Jersey (smallest change) +2%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 4 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
A-S Medication Solutions
| Strength | Looks like | Imprint |
|---|---|---|
| 1 g | white capsule, 20 mm, scored to split in 2 | 675 |
Allergan, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 1 g | pink oval tablet, 10 mm, scored to split in 2 | CARAFATE 1712 |
Bryant Ranch Prepack
| Strength | Looks like | Imprint |
|---|---|---|
| 1 g | white capsule, 20 mm, scored to split in 2 | 675 |
Cardinal Health 107, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 1 g | pink suspension | |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
2 recalls since 2020
- Oct 2023 · Vistapharm LLC · Class I
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus. - Aug 2023 · Vistapharm LLC · Class II
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.